Category:Pediatric
Status:Active
The purpose of this study is to assess the safety, tolerability and efficacy of a new drug aimed at controlling disease activity in patients diagnosed with primary haemophagocytic lymphohistiocytos...
Diagnosis: Pediatric Histiocytosis
Phase: 2 / 3
Protocol Number: 14-018
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Diagnosis: Pediatric Histiocytosis
Phase: 2 / 3
Protocol Number: 13-428
Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis
This research study is evaluating a drug called clofarabine as a possible treatment for Langerhans Cell Histiocytosis( LCH )
Diagnosis: Pediatric Histiocytosis
Phase: 2
Protocol Number: 15-005